Nagasako Elna M, Johnson Robert W, Griffin David R J, Dworkin Robert H
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, New York, USA.
J Am Acad Dermatol. 2002 Jun;46(6):834-9. doi: 10.1067/mjd.2002.120924.
Baseline and follow-up data from 4 samples of immunocompetent patients with herpes zoster who participated in clinical trials of the antiviral agent famciclovir were examined (N = 1778). In both univariate and multivariate analyses, severe rash (ie, >50 lesions, defined as papules, vesicles, or crusted vesicles) was significantly associated with older age, male sex, severe pain, primary involvement of nontrigeminal dermatomes, and a greater number of affected dermatomes. In addition, severe rash predicted the presence of pain 3 months later. The results indicate that severe rash is more common in patients with herpes zoster who are older and who have more severe acute pain and confirm that severe rash is a risk factor for prolonged pain.
对参与抗病毒药物泛昔洛韦临床试验的4组免疫功能正常的带状疱疹患者的基线和随访数据进行了检查(N = 1778)。在单变量和多变量分析中,严重皮疹(即>50个皮损,定义为丘疹、水疱或结痂水疱)与年龄较大、男性、严重疼痛、非三叉神经皮节的原发性受累以及更多受累皮节显著相关。此外,严重皮疹预示3个月后会出现疼痛。结果表明,严重皮疹在年龄较大、急性疼痛更严重的带状疱疹患者中更常见,并证实严重皮疹是疼痛持续时间延长的一个危险因素。